These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10220543)

  • 21. Comparative accuracy of cardiovascular risk prediction methods in patients with diabetes mellitus.
    Game FL; Bartlett WA; Bayly GR; Jones AF
    Diabetes Obes Metab; 2001 Aug; 3(4):279-86. PubMed ID: 11520308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How generalizable are coronary risk prediction models? Comparison of Framingham and two national cohorts.
    Liao Y; McGee DL; Cooper RS; Sutkowski MB
    Am Heart J; 1999 May; 137(5):837-45. PubMed ID: 10220632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of Framingham cardiovascular disease (CVD) predictions in the Rotterdam Study taking into account competing risks and disentangling CVD into coronary heart disease (CHD) and stroke.
    van Kempen BJ; Ferket BS; Kavousi M; Leening MJ; Steyerberg EW; Ikram MA; Witteman JC; Hofman A; Franco OH; Hunink MG
    Int J Cardiol; 2014 Feb; 171(3):413-8. PubMed ID: 24438922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Framingham risk function underestimated absolute coronary heart disease risk in Czech men.
    Reissigová J; Zvárová J
    Methods Inf Med; 2007; 46(1):43-9. PubMed ID: 17224979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Coronary risk estimation in Spain using a calibrated Framingham function].
    Marrugat J; Solanas P; D'Agostino R; Sullivan L; Ordovas J; Cordón F; Ramos R; Sala J; Masià R; Rohlfs I; Elosua R; Kannel WB
    Rev Esp Cardiol; 2003 Mar; 56(3):253-61. PubMed ID: 12622955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pravastatin. A pharmacoeconomic review of its use in primary and secondary prevention of coronary heart disease.
    Coukell AJ; Wilde MI
    Pharmacoeconomics; 1998 Aug; 14(2):217-36. PubMed ID: 10186462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport.
    Assmann G; Schulte H; von Eckardstein A; Huang Y
    Atherosclerosis; 1996 Jul; 124 Suppl():S11-20. PubMed ID: 8831911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ten-year risk prediction in French men using the Framingham coronary score: results from the national SU.VI.MAX cohort.
    Vergnaud AC; Bertrais S; Galan P; Hercberg S; Czernichow S
    Prev Med; 2008 Jul; 47(1):61-5. PubMed ID: 18456313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of FRAMINGHAM, PROCAM and SCORE models in Turkish people with Type 2 diabetes: comparison of three cardiovascular risk calculations.
    Bayındır Çevik A; Özcan Ş; Satman İ
    Contemp Nurse; 2015; 50(2-3):183-95. PubMed ID: 26503421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham risk score.
    Balady GJ; Larson MG; Vasan RS; Leip EP; O'Donnell CJ; Levy D
    Circulation; 2004 Oct; 110(14):1920-5. PubMed ID: 15451778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validity of the Framingham point scores in the elderly: results from the Rotterdam study.
    Koller MT; Steyerberg EW; Wolbers M; Stijnen T; Bucher HC; Hunink MG; Witteman JC
    Am Heart J; 2007 Jul; 154(1):87-93. PubMed ID: 17584559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the performance of the Framingham risk equations in a population with diabetes.
    McEwan P; Williams JE; Griffiths JD; Bagust A; Peters JR; Hopkinson P; Currie CJ
    Diabet Med; 2004 Apr; 21(4):318-23. PubMed ID: 15049932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary and cardiovascular risk estimation in uncomplicated mild hypertension. A comparison of risk assessment methods.
    Yikona JI; Wallis EJ; Ramsay LE; Jackson PR
    J Hypertens; 2002 Nov; 20(11):2173-82. PubMed ID: 12409955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women.
    Tonstad S; Hjermann I
    J Cardiovasc Risk; 2003 Apr; 10(2):129-35. PubMed ID: 12668910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey.
    Ko M; Kim MT; Nam JJ
    Int J Cardiol; 2006 Jun; 110(2):184-90. PubMed ID: 16412525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary risk versus cardiovascular risk for treatment decisions in mild hypertension.
    Yeo WW; Yeo KR
    J Cardiovasc Risk; 2002 Oct; 9(5):275-80. PubMed ID: 12394321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular risk factors and endothelial dysfunction.
    Wierzbicki AS; Chowienczyk PJ; Cockcroft JR; Brett SE; Watts GF; Jenkins BS; Ritter JM
    Clin Sci (Lond); 2004 Dec; 107(6):609-15. PubMed ID: 15450002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimation of CHD risk in a French working population using a modified Framingham model. The PCV-METRA Group.
    Laurier D; Nguyen PC; Cazelles B; Segond P
    J Clin Epidemiol; 1994 Dec; 47(12):1353-64. PubMed ID: 7730844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study.
    Brindle P; Emberson J; Lampe F; Walker M; Whincup P; Fahey T; Ebrahim S
    BMJ; 2003 Nov; 327(7426):1267. PubMed ID: 14644971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PROCAM-, FRAMINGHAM-, SCORE- and SMART-risk score for predicting cardiovascular morbidity and mortality in patients with overt atherosclerosis.
    Uthoff H; Staub D; Socrates T; Meyerhans A; Bundi B; Schmid HP; Frauchiger B
    Vasa; 2010 Nov; 39(4):325-33. PubMed ID: 21104622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.